Researchers have shown that HCC cells activate liver fibroblast conversion to CAFs by secreting tissue inhibitor of metalloproteinase-1 (TIMP-1), and the latter can promote HCC growth through the IL-6/STAT3 pathway [28]. Here, STAT3 is linked to hepatocellular carcinoma.